370 results on '"de Vries-Bouwstra, Jeska"'
Search Results
2. Practical guidance for the early recognition and follow-up of patients with connective tissue disease-related interstitial lung disease
3. Anti-carbamylated protein antibodies in systemic sclerosis
4. Does the Impact of COVID‐19 on Patients With Systemic Sclerosis Change Over Time?
5. Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium
6. Troponin I levels in systemic sclerosis patients with myocardial involvement
7. Untangling the relationship between smoking and systemic sclerosis: an analysis of the EUSTAR cohort
8. Does a history of smoking increase the risk of developing systemic sclerosis? Insights from the Leiden systemic sclerosis cohort
9. Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort
10. Sex-specific risk of anti-topoisomerase antibodies on mortality and disease severity in systemic sclerosis: 10-year analysis of the Leiden CCISS and EUSTAR cohorts
11. Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials
12. Systemic sclerosis in the time of COVID-19
13. Exploring the effects of a combined exercise programme on pain and fatigue outcomes in people with systemic sclerosis: study protocol for a large European multi-centre randomised controlled trial
14. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
15. Physical Therapy in Systemic Sclerosis: The Patient Perspective
16. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
17. The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET
18. Publisher Correction: The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET
19. Sex-specific difference in cardiac function in patients with systemic sclerosis: association with cardiovascular outcomes
20. Detection of Systemic Sclerosis-associated Interstitial Lung Disease by Exhaled Breath Analysis Using Electronic Nose Technology.
21. Long noncoding RNA H19X is a key mediator of TGF-[beta]-driven fibrosis
22. Lung function is associated with minimal EQ-5D changes over time in patients with systemic sclerosis
23. The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis—Interstitial Lung Disease in the European Scleroderma Trial and Research Database.
24. Screening for ILD in RA: a survey of 1132 patients with RA
25. RA-ILD – new insights into disease burden from an international patient survey
26. Does the impact of COVID‐19 on patients with systemic sclerosis change over time?
27. Epicardial adipose tissue in patients with systemic sclerosis
28. Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis
29. Antisense Long Non-Coding RNAs Are Deregulated in Skin Tissue of Patients with Systemic Sclerosis
30. The long-term course of the Health Assessment Questionnaire in patients with systemic sclerosis
31. Interstitial Lung Disease
32. Step forward in early recognition of systemic sclerosis: data from the Leiden CCISS cohort
33. Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database
34. Riociguat in systemic sclerosis: challenges in crossing the bridge from bench to bedside
35. Whole body insulin sensitivity is increased in systemic sclerosis
36. Comment on: Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database
37. Autoreactive B cell responses targeting nuclear antigens in systemic sclerosis: Implications for disease pathogenesis
38. Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies
39. Automatic pulmonary function estimation from chest CT scans using deep regression neural networks: the relation between structure and function in systemic sclerosis
40. sj-pdf-1-jso-10.1177_23971983231181719 – Supplemental material for The long-term course of the Health Assessment Questionnaire in patients with systemic sclerosis
41. Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis
42. Identification of regulators of the myofibroblast phenotype of primary dermal fibroblasts from early diffuse systemic sclerosis patients
43. Lung structure and function relation in systemic sclerosis: Application of lung densitometry
44. Mouth opening in systemic sclerosis: Its course over time, determinants and impact on mouth handicap
45. Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort
46. Improvement of microangiopathy after haematopoietic stem cell transplantation in systemic sclerosis
47. Exploring the effects of a combined exercise programme on pain and fatigue outcomes in people with systemic sclerosis: Study protocol for a large European multi-centre randomised controlled trial.
48. Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort
49. Clinical characteristics of juvenile onset systemic sclerosis patients from the juvenile scleroderma inception cohort compared to adult age juvenile-onset patients from EUSTAR. Are these differences suggesting risk for mortality?
50. Reply
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.